6505-01-492-8089 ( NDC00085-1777-01 , NDC50419-0777-01 , 01-0682 , CIPRO )

NSN Information
NSN FSC NIIN Item Name INC
6505-01-492-8089 6505 014928089 CIPROFLOXACIN ORAL SUSPENSION 7777
NSN Features
MRC Parameter Characteristics
CXCY PART NAME ASSIGNED BY CONTROLLING AGENCY CIPROFLOXACIN SUSPENSION 250MG/5ML 100ML AFTER RECONSTITUTION
FEAT SPECIAL FEATURES CIPROFLOXACIN MICROENCAPSULATED; 250 MG PER 5 ML, 100 ML AFTER RECONSTITUTION, ORAL SUSPENSION; THE DRUG IS COMPOSED OF TWO COMPONENTS (MICROCAPSULES AND DILUENT); STORE BELOW 25 DEGREES C (77 DEGREES F) PROTECT FROM FREEZING
Manufacturing Part Numbers (SKUs)
Part SKU Cage Status RNVC RNCC SADC DAC RNAAC
NDC00085-1777-01 1F095 A 2 3 4 ZZ
NDC50419-0777-01 13521 A 2 3 4 ZZ
01-0682 89875 A 1 5 4 ZZ
CIPRO 1F095 A 1 5 4 ZZ
Manufacturers
Part SKU Cage Manufacturer Type Status
NDC00085-1777-01 1F095 SCHERING-PLOUGH CORPORATION A A
NDC50419-0777-01 13521 BAYER PHARMACEUTICALS CORPORATIO A A
01-0682 89875 DEFENSE LOGISTICS AGENCY A A
CIPRO 1F095 SCHERING-PLOUGH CORPORATION A A
FLIS Identification
PMIC ADPE Code CRITL Code DEMIL Code DEMIL INTG NIIN Asgt ESD HMIC ENAC Schedule-B INC
A X A 1 12/13/2 P 7777
FLIS Management
MOE REC Rep Code Mgmt Ctl USC Phrase Code Phrase Statement
DN 9B----- N K U/I CONTAINS 100 ML
DF ------- F K U/I CONTAINS 100 ML
DA C2201X- A K U/I CONTAINS 100 ML
DS I K U/I CONTAINS 100 ML
Demilitarization Codes & Management
DML PMI HMIC ADP CC ESDC
A A P X
Miscellaneous Management
MOE (S_A) SOS AAC QUP UI SLC CIIC RC MCC SVC
DF SMS L 1 BT M U ------- F
DS SMS L 1 BT M U D
DA SMS L 1 BT M U C2201X- A
DN SMS L 1 BT M U 9B----- N
Management Control Army
MATCAT 1 MATCAT 2 MATCAT 3 MATCAT 4 5 ARC
C 2 2 01 X
Freight
NMFC NMFC SUB UFC HMC LTL LCL WCC TCC SHC ADC ACC ASH NMF DESC
058770 Z 33800 W 532 Z 9 A M Z DRUGS/MEDICINES/VITAMINS NOI